These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 28315609

  • 1. The levonorgestrel-releasing intrauterine device potentiates stress reactivity.
    Aleknaviciute J, Tulen JHM, De Rijke YB, Bouwkamp CG, van der Kroeg M, Timmermans M, Wester VL, Bergink V, Hoogendijk WJG, Tiemeier H, van Rossum EFC, Kooiman CG, Kushner SA.
    Psychoneuroendocrinology; 2017 Jun; 80():39-45. PubMed ID: 28315609
    [Abstract] [Full Text] [Related]

  • 2. Changes in hair cortisol concentration in intrauterine device initiators: A prospective cohort study.
    Doty N, Beckley E, Garg B, Maristany S, Erikson DW, Jensen JT.
    Contraception; 2023 Dec; 128():110142. PubMed ID: 37633589
    [Abstract] [Full Text] [Related]

  • 3. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
    Kudielka BM, Schmidt-Reinwald AK, Hellhammer DH, Kirschbaum C.
    Neuroendocrinology; 1999 Dec; 70(6):422-30. PubMed ID: 10657735
    [Abstract] [Full Text] [Related]

  • 4. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis.
    Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH.
    Psychosom Med; 1999 Dec; 61(2):154-62. PubMed ID: 10204967
    [Abstract] [Full Text] [Related]

  • 5. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K, Reed S, Moehner S, Minh TD.
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [Abstract] [Full Text] [Related]

  • 6. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E, Malinen H, Sundström H, Penttinen J, Kauppila A.
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [Abstract] [Full Text] [Related]

  • 7. Changes in body composition in women using long-acting reversible contraception.
    Silva Dos Santos PN, Madden T, Omvig K, Peipert JF.
    Contraception; 2017 Apr; 95(4):382-389. PubMed ID: 28041992
    [Abstract] [Full Text] [Related]

  • 8. Levonorgestrel levels in serum and uterine flushings in women bearing LNG-Cu-IUD.
    Shi JP, Wu XR.
    J Tongji Med Univ; 1993 Apr; 13(2):126-8. PubMed ID: 8230357
    [Abstract] [Full Text] [Related]

  • 9. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J, Heikinheimo O, Lähteenmäki P, Suhonen S.
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [Abstract] [Full Text] [Related]

  • 10. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L, Bottura BF, Bahamondes MV, Gonçalves MP, Correia VM, Espejo-Arce X, Sousa MH, Monteiro I, Fernandes A.
    Hum Reprod; 2014 Oct 10; 29(10):2163-70. PubMed ID: 25085802
    [Abstract] [Full Text] [Related]

  • 11. Acceptability of intrauterine contraception among women living with human immunodeficiency virus: a randomised clinical trial.
    Kakaire O, Tumwesigye NM, Byamugisha JK, Gemzell-Danielsson K.
    Eur J Contracept Reprod Health Care; 2016 Jun 10; 21(3):220-6. PubMed ID: 26895345
    [Abstract] [Full Text] [Related]

  • 12. Hypothalamic-pituitary-adrenal axis response to acute psychosocial stress: Effects of biological sex and circulating sex hormones.
    Stephens MA, Mahon PB, McCaul ME, Wand GS.
    Psychoneuroendocrinology; 2016 Apr 10; 66():47-55. PubMed ID: 26773400
    [Abstract] [Full Text] [Related]

  • 13. Characteristics and hormonal contraception use patterns of levonorgestrel 13.5 mg intrauterine device users in Sweden 2014-2016.
    Linder M, Schoendorf J, Pisa F, Schulze-Rath R, Cesta CE.
    Contraception; 2024 Mar 10; 131():110309. PubMed ID: 37844683
    [Abstract] [Full Text] [Related]

  • 14. Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam.
    Fries E, Hellhammer DH, Hellhammer J.
    Psychoneuroendocrinology; 2006 Nov 10; 31(10):1278-88. PubMed ID: 17097811
    [Abstract] [Full Text] [Related]

  • 15. The levonorgestrel-releasing intrauterine device.
    Toivonen J.
    Adv Contracept Deliv Syst; 1994 Nov 10; 10(3-4):191-8. PubMed ID: 12287838
    [Abstract] [Full Text] [Related]

  • 16. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P, Lähteenmäki P, Rutanen EM.
    Acta Obstet Gynecol Scand; 1999 May 10; 78(5):423-8. PubMed ID: 10326889
    [Abstract] [Full Text] [Related]

  • 17. Effect of Norplant implants on the pituitary-adrenal axis function and reserve capacity.
    Toppozada MK, Ramadan M, el-Sawi M, Mehanna MT, Khamis Y, Marzouk S.
    Contraception; 1997 Jan 10; 55(1):7-10. PubMed ID: 9013054
    [Abstract] [Full Text] [Related]

  • 18. Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system.
    Simonatto P, Bahamondes MV, Fernandes A, Silveira C, Bahamondes L.
    J Obstet Gynaecol Res; 2016 May 10; 42(5):554-9. PubMed ID: 26817571
    [Abstract] [Full Text] [Related]

  • 19. Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma.
    Xie ZW, Zhang YN, Wan S, Xu WZ, Chen J.
    J Int Med Res; 2012 May 10; 40(5):1966-72. PubMed ID: 23206480
    [Abstract] [Full Text] [Related]

  • 20. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N, Bahamondes L, Bahamondes MV, de Oliveira Santos A, Monteiro I.
    Contraception; 2012 Oct 10; 86(4):350-3. PubMed ID: 22445431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.